1. Catalog
  2. PrEP 101: A Hospitalist's Guide to HIV Pre-Exposur ...
PrEP 101: A Hospitalist's Guide to HIV Pre-Exposure Prophylaxis
LGBTQ+ patients face unique challenges that results in worse health outcomes, many of these are amplified when patients require hospitalization. To provide the highest value of care, Hospitalists must be aware of these challenges. This session is part of a series meant to prepare hospitalists to provide patient-centric care for LGBTQ+ patients.
Create Account
Availability
On-Demand
Expires on Mar 05, 2027
Cost
$0.00
Credit Offered
0.25 CME Credit
0.25 ABIM-MOC Point
0.25 Participation Credit
  • Overview
  • Overview
  • Faculty
  • Recommended
Learning Objectives
After completing this activity, learners should be able to:
  1. Recognize LGBTQ+ as a social determinant of health.
  2. Document using language that is consistent with patients’ sexual orientation and gender-identity.
  3. Recognize that risk scoring systems and laboratory reference ranges are not validated for transgender patients.
  4. <li">Described the risk of abruptly stopping gender-affirming hormone therapy.
  5. Describe best-practices for pre-exposure prophylaxis (PreP) therapy while patients are admitted to the hospital.
  6. Identify methods to advocate for LGBTQ+ patients.
  7. Apply methods for discussing gender identity, organ inventory, and sexual orientation with patients.
This content developed out of work by the LGBTQ+ Task Force of the SHM Education Committee.

Description
LGBTQ+ patients face unique challenges that results in worse health outcomes, many of these are amplified when patients require hospitalization. To provide the highest value of care, Hospitalists must be aware of these challenges. This session is part of a series meant to prepare hospitalists to provide patient-centric care for LGBTQ+ patients.

Learning Objectives

  1. Recognize LGBTQ+ as a social determinant of health.
  2. Document using language that is consistent with patients’ sexual orientation and gender-identity.
  3. Recognize that risk scoring systems and laboratory reference ranges are not validated for transgender patients.
  4. Describe the risk of abruptly stopping gender-affirming hormone therapy.
  5. Describe best-practices for pre-exposure prophylaxis (PreP) therapy while patients are admitted to the hospital.
  6. Identify methods to advocate for LGBTQ+ patients.
  7. Apply methods for discussing gender identity, organ inventory, and sexual orientation with patients.
Faculty
  • Aniruddha (Anu) Hazra, MD
Faculty Disclosures
The faculty and planners of these activities have no relevant relationships to disclose. All relevant relationships were mitigated prior to the start of this activity.

Conflict of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.

Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.

IOS App Download Powered By